Lacosamide Tablet
Product Images NDC 53746-925

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 53746-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 1)

FDA Label Image

2 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 2)

2 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg  2)
The given text is a visual representation of Figure 1 that shows the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose. The graph depicts three studies - Study 2, Study 3, and Study 4 - with different medications - Tocosamde, Lacosamide, and Placato - and their corresponding seizure reduction rates. The statistical significance of the difference compared to Placebo is denoted by an asterisk (*).*
FDA Label Image

3 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 3)

3 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg  3)
This is a graph showing the proportion of patients who responded favorably to Lacosamide compared to a Placebo in Studies 2, 3, and 4. The Y-axis is labeled as "Responder Rate" and the X-axis shows the different doses administered. The graph indicates that patients on higher doses of Lacosamide had a higher responder rate compared to those on a placebo. The text also includes a table showing the number of patients for each treatment group.*
FDA Label Image

4 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 4)

4 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg  4)
This is a medication guide for Lacosamide Tablets, USP, which is intended to be given to each patient. The guide provides information on dosages, administration, and potential side effects of the medication. The NDC number for this medication is 53746-923-60. The rest of the text contains some product codes and contact information, but it is difficult to understand the context.*
FDA Label Image

5 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 5)

5 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg  5)
This appears to be a document relating to medication, particularly a packet of tablets with a dosage of 100 mg per tablet. The medication is listed as "Lacosamide" and is available only with a prescription. The document includes a barcode that may potentially lead to more information about the medication.*
FDA Label Image

6 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 6)

6 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg  6)
This appears to be a label for medication, specifically Lacosamide Tablets. It includes the dosage, quantity (60 tablets), and a National Drug Code (NDC) number. It also includes instructions for pharmacists to dispense to each patient and a warning that it is only available by prescription (Rx Only).*
FDA Label Image

7 (Lacosamide Tablets Usp 50 mg 100 mg 150 mg 200 mg 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.